SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-003931
Filing Date
2024-01-08
Accepted
2024-01-08 08:05:32
Documents
14
Period of Report
2024-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d110151d8k.htm   iXBRL 8-K 29952
2 EX-99.1 d110151dex991.htm EX-99.1 16486
6 GRAPHIC g110151g0105184155850.jpg GRAPHIC 3258
  Complete submission text file 0001193125-24-003931.txt   185049

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vera-20240103.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20240103_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20240103_pre.xml EX-101.PRE 11697
8 EXTRACTED XBRL INSTANCE DOCUMENT d110151d8k_htm.xml XML 3484
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 24518428
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)